Hologic, Inc. (HOLX) Free Cash Flow (FCF): $999.60M
The free cash flow (FCF) for Hologic, Inc. (HOLX) is $999.60M. It is below its 12-month average by 3.19% ($1.03B).
HOLX Free Cash Flow (FCF) Chart
HOLX Average Free Cash Flow (FCF) Chart
HOLX Current vs Average Free Cash Flow (FCF) Chart
HOLX Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$999.60M
FREE CASH FLOW (FCF) AVG TTM
$1.03B
FREE CASH FLOW (FCF) AVG 3Y
$1.24B
FREE CASH FLOW (FCF) AVG 5Y
$1.31B
FREE CASH FLOW (FCF) AVG 10Y
$936.98M
FREE CASH FLOW (FCF) AVG 15Y
$763.87M
FREE CASH FLOW (FCF) AVG 20Y
$627.21M
CURRENT VS TTM AVG
-3.19%
CURRENT VS 3Y AVG
-19.46%
CURRENT VS 5Y AVG
-23.67%
CURRENT VS 10Y AVG
+6.68%
CURRENT VS 15Y AVG
+30.86%
CURRENT VS 20Y AVG
+59.37%
FCF Analysis
Free Cash Flow (TTM)
$999.60M
FCF Yield
5.82%
Price/FCF
17.2
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Hologic, Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hologic, Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The free cash flow (FCF) for HOLX stock is $999.60M.
- What is the TTM average free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The TTM average free cash flow (FCF) for HOLX stock is $1.03B.
- What is the 3Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The 3Y average free cash flow (FCF) for HOLX stock is $1.24B.
- What is the 5Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The 5Y average free cash flow (FCF) for HOLX stock is $1.31B.
- What is the 10Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The 10Y average free cash flow (FCF) for HOLX stock is $936.98M.
- What is the 15Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The 15Y average free cash flow (FCF) for HOLX stock is $763.87M.
- What is the 20Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
- The 20Y average free cash flow (FCF) for HOLX stock is $627.21M.
Hologic, Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-09-27 | $920.10M |
| 2024-09-30 | $1.15B |
| 2023-09-30 | $901.00M |
| 2022-09-30 | $2.00B |
| 2021-09-30 | $2.15B |
| 2020-09-30 | $740.20M |
| 2019-09-30 | $535.90M |
| 2018-09-30 | $627.30M |
| 2017-09-30 | $-99.30M |
| 2016-09-30 | $688.70M |
| 2015-09-30 | $696.70M |
| 2014-09-30 | $428.20M |
| 2013-09-30 | $403.69M |
| 2012-09-30 | $286.95M |
| 2011-09-30 | $392.02M |
| 2010-09-30 | $404.23M |
| 2009-09-30 | $480.66M |
| 2008-09-30 | $311.31M |
| 2007-09-30 | $130.41M |
| 2006-09-30 | $-9.46M |
| 2005-09-30 | $36.67M |
| 2004-09-30 | $18.70M |
| 2003-09-30 | $-3.42M |
| 2002-09-30 | $823000.00 |
| 2001-09-30 | $-14.58M |
| 2000-09-30 | $-6.50M |
| 1999-09-30 | $-6.60M |
| 1998-09-30 | $-8.00M |
| 1997-09-30 | $10.50M |
| 1996-09-30 | $-1.30M |
Related Metrics
About Hologic, Inc.
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Malenchini